mk2 Biotechnologies participated as emerging startup at the BioVaria 2018 in Munich, Germany. The oral and poster presentations catalyzed fruitful discussions with technology experts from industry and finance underlining the importance of new peptide synthesis technologies.
mk2 Biotechnologies is supported by the Bavarian Ministry of Economic Affairs and Media, Energy and Technology through the funding program FLÜGGE. The competent jury considered the innovative peptide synthesis technology by mk2 Biotechnologies to provide outstanding opportunities for several applications. The technological advances of simultaneous high purities, authentic amino [...]
mk2 Biotechnologies won the 1st price of the TUM IdeAward 2016. The competition is run annually by the Technical University of Munich (TUM), UnternehmerTUM, and the Zeidler Research Foundation. The competition jury adjuged mk2 Biotechnologies to be the most promising project out of the 46 participating teams. More information [...]
